Related Experiment Video

Updated: Dec 19, 2025

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

13.8K

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer

Sandra Muñoz-Galván1,2, Amancio Carnero1,2

  • 1Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n, 41013 Seville, Spain.

Cells
|June 10, 2020
PubMed

Insights

Ovarian cancer stem cells drive treatment resistance and metastasis. Targeting these cells offers a promising strategy to improve survival rates and prevent recurrence in ovarian cancer patients.

Area of Science:

  • Gynecological Oncology
  • Cancer Stem Cell Biology
  • Tumor Microenvironment Interactions

Background:

  • Ovarian cancer is a lethal malignancy with high recurrence rates, often linked to therapeutic resistance.
  • Cancer stem cells (CSCs) within tumors possess self-renewal capabilities, driving tumor growth, metastasis, and resistance to conventional treatments.
  • Understanding CSC biology is crucial for developing effective ovarian cancer therapies.

Purpose of the Study:

  • To review current knowledge on ovarian cancer stem cells (CSCs).
  • To explore the role of CSCs in metastasis and tumor microenvironment interactions.
  • To discuss therapeutic strategies targeting CSCs for preventing ovarian cancer relapse.

Main Methods:

  • Literature review of recent studies on ovarian cancer stem cells.
  • Analysis of identified CSC markers and signaling pathways.
  • Synthesis of information on CSC interactions with the tumor microenvironment.
  • Evaluation of therapeutic approaches targeting CSCs.

Main Results:

  • Ovarian CSCs exhibit stem-like properties enabling tumor recapitulation and therapy resistance.
  • Specific markers and signaling pathways are identified as critical for CSC self-renewal.
  • CSCs play a significant role in ovarian cancer metastasis and interact dynamically with their microenvironment.

Conclusions:

  • Targeting ovarian CSCs is a key strategy to overcome treatment resistance and reduce mortality.
  • Further research is needed to fully elucidate CSC mechanisms in therapy resistance.
  • Developing targeted therapies against CSCs holds promise for preventing tumor relapse in ovarian cancer.
Keywords:
cancer stem cellsovarian cancertherapy resistance

More Related Videos

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.6K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.6K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K